RCL ROYAL CARIBBEAN GROUP
FollowStock (common), issuer CIK 884887
1,203 managers (1,244 13F filers) reported a position in RCL shares at 2026-06-30, 237,323,290 shares in all. 154 filers opened a position and 102 filers sold out during the quarter.
- Managers
- 1,203
- 13F filers
- 1,244
- New
- 154
- Added
- 443
- Reduced
- 460
- Sold out
- 102
- Shares held by filers
- 237,323,290
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Capital Research Global Investors(group Capital Research Global Investors)
17,152,902 shares, 6.4% in a 13G/A as of 2026-09-30,0001422848-26-000124
Accepted , ingested
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -3,833 S | $324.35 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -38,034 S | $323.35 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -10,754 S | $322.42 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -13,534 S | $321.61 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -4,075 S | $320.26 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -4,245 S | $319.05 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -6,869 S | $318.06 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-13 | -6,982 S | $317.67 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -350 S | $334.04 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -594 S | $333.29 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -6,804 S | $332.25 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -3,866 S | $329.34 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -2,425 S | $324.31 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -2,029 S | $323.08 | Form 4 |
| Wilhelmsen Arne Alexanderdirector | 2026-11-12 | -18,932 S | $322.3 | Form 4 |
13F holders, Q2 2026
Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GHP Investment Advisors, Inc. | 1 | $318 | <0.01% | 0 | 13F-HRTimeline |
| Asset Dedication, LLC | 1 | $318 | <0.01% | new | 13F-HRTimeline |
| MCGUIRE CAPITAL ADVISORS INC | 1 | $318 | <0.01% | 0 | 13F-HRTimeline |
Events
Wilhelmsen Arne Alexander sold 88,326 RCL shares on 2026-11-13, Form 4 filed 2026-11-16. 0001317345-26-000024
Accepted , ingestedWilhelmsen Arne Alexander sold 185,000 RCL shares between 2026-11-11 and 2026-11-12, Form 4 filed 2026-11-13. 0001317345-26-000022
Accepted , ingestedWilhelmsen Arne Alexander sold 476,674 RCL shares between 2026-11-06 and 2026-11-10, Form 4 filed 2026-11-10. 0001317345-26-000020
Accepted , ingestedWilhelmsen Arne Alexander sold 250,000 RCL shares between 2026-11-04 and 2026-11-05, Form 4 filed 2026-11-06. 0001317345-26-000018
Accepted , ingestedFain Richard D disposed of 5,605 RCL shares on 2026-11-02, Form 4 filed 2026-11-04. 0001316987-26-000004
Accepted , ingestedLake Robert Alexander sold 1,000 RCL shares on 2026-11-02, Form 4 filed 2026-11-03. 0001697820-26-000011
Accepted , ingestedMontiel Maritza Gomez sold 400 RCL shares on 2026-10-30, Form 4 filed 2026-10-30. 0001640081-26-000007
Accepted , ingestedLake Robert Alexander sold 1,000 RCL shares on 2026-10-28, Form 4 filed 2026-10-30. 0001697820-26-000009
Accepted , ingestedCapital Research Global Investors reported 17,152,902 RCL shares, 6.4% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-06. 0001422848-26-000124
Accepted , ingested